Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia Areata affects both patients and their cohabitants' quality of life and emotional well-being.

Women with Polycystic Ovary Syndrome (PCOS) often have higher levels of anxiety and depression, especially if they live in rural areas, have less education, don't have children, are over 30, or are obese.

Androgenetic alopecia causes significant psychological distress, especially in women, and requires both medical and psychological support.

Hair transplantation improves self-esteem and social confidence, but managing expectations and psychological risks is crucial for success.

Women with PCOS experience more psychological symptoms and need emotional support.

Adults and adolescents with severe alopecia areata are willing to take significant health risks for a better chance of hair regrowth.

People with hair loss are more likely to have anxiety.

People with alopecia often feel anxious, depressed, and have low self-esteem.

Women are more likely to have long-term post-COVID symptoms than men.

Long COVID symptoms are linked to immune issues, poor blood flow, and lung problems.

The DLQI is a key tool for measuring quality of life in dermatology.

Alopecia areata greatly affects people's life quality, mental health, and work life.

The Dermatology Life Quality Index is reliable and consistent but needs more diverse participant studies.

Experts recommend personalized treatment plans for alopecia areata, using corticosteroids and minoxidil for mild cases, and stronger medications for severe cases.

Bariatric surgery improves ovulation rates in women with PCOS and obesity better than medical therapy.

5-alpha reductase inhibitors, like finasteride and dutasteride, may cause depression, but more research is needed to understand why.

Isotretinoin treatment in Palestine shows poor adherence to guidelines, with common side effects and a need for better prescribing practices and patient education.

The review found that current care models for PCOS are not fully effective and more research is needed, especially in low-income countries.

Telemedicine is effective for managing alopecia areata follow-ups.

Women with PCOS often face anxiety, depression, and low body appreciation, especially if they have alopecia, obesity, or a history of mental health issues.

Depression and skin autoimmune diseases are linked, needing combined care for better treatment.

Keratinocyte Growth Factor-Hair Serum may help prevent hair loss during chemotherapy, but more research is needed.

New-onset fibromyalgia after COVID-19 is poorly understood and needs more research.

Addressing alexithymia can improve anxiety and depression in alopecia areata patients.

Hair loss can affect mood, self-esteem, body image, and quality of life.

Collaboration and innovation are key to developing effective, safe hair loss treatments.

Managing inflammation and using vitamins can improve PRP therapy for better hair growth.

Listening to music can help reduce anxiety before hair transplant surgery.

Androgenetic alopecia negatively affects emotions and self-confidence, especially in younger people.

Hair specialists vary in testing for alopecia areata, highlighting the need for standard guidelines.